Watch the webinar and download the presentation

Vironova’s smörgåsbord of gene therapy analysis solutions


On November 3rd, Vironova together with Biogen participated as experts in a webinar hosted by BioPharma AsiaYou can watch the webinar on demand, and  download the presentation used by Vironova's Dr. Saba Hussein Gore.

One of the biggest challenges for AAV gene therapy products is establishing an appropriate analytical strategy to support product manufacture, release, stability, comparability and characterization at different stages of development. This presentation will highlight some of the existing analytical challenges and provide guidance on development of an appropriate strategy to help overcome these.

What you can expect from the webinar and presentation

  • Highlights of some of our clients’ AAV production-related questions and challenges
  • Possible solutions to address Analytical Challenges for Gene Therapy with Electron Microscopy and Intelligent Software

Dr. Saba Hussein Gore is an applications manager and senior scientist at Vironova, where she leads the global team of Applications Specialists, based in Stockholm, Sweden. She has a BSc in Virology from the University of Warwick, UK, an MSc in Virology from Imperial College London, UK, and a PhD in the structure and function of membrane proteins from the Laboratory of Molecular Biology (LMB) at the University of Cambridge, UK. She has previously worked as a technician and project manager at Imperial College London in a Gates Grand Challenges in Global Health HIV vaccine consortium, as a postdoctoral fellow in structural and molecular biology of membrane proteins at NYU, USA, and at Stockholm University, Sweden, and as a protein scientist at Sobi, Sweden. She has several publications in leading journals and has presented at leading conferences and engaged with biopharmaceutical clients in Asia, Europe and the USA.


Access webinar and documents